Which concern is NOT typically related to physician perspective on dual antiplatelet therapy (DAPT)?

• A. Late stent thrombosis (ST)
• B. Cost-effectiveness
• C. Bleeding risks
• D. DAPT responsiveness

Answer: (B)

The choice regarding cost-effectiveness is typically not a primary concern from a physician's perspective when discussing dual antiplatelet therapy (DAPT). Physicians generally prioritize patient safety and treatment efficacy over costs when determining the best course of action for their patients.

In the context of DAPT, concerns such as late stent thrombosis, bleeding risks, and DAPT responsiveness are critical. Late stent thrombosis refers to the risk of clot formation occurring at the site of a stent after the initial implantation period, which can lead to serious complications. Bleeding risks involve the potential for patients to experience significant bleeding episodes associated with the use of antiplatelet medications. DAPT responsiveness pertains to how well a patient responds to the treatment, which can vary among individuals and impact the effectiveness of therapy. Therefore, while cost-effectiveness might be a consideration in broader healthcare discussions, it is not typically a primary focus for physicians when assessing the immediate risks and benefits of DAPT for their patients.